COBALT advised STADA Arzneimittel on the acquisition of Walmark

COBALT was the local counsel in the Baltics to STADA Arzneimittel on the acquisition of Walmark, a leading manufacturer of consumer health products in Central Europe from Mid Europa Partners for an undisclosed amount.

Walmark has a unique portfolio of well-established consumer health brands across multiple categories, direct presence across nine European Union countries, including Czech Republic, Slovakia, Poland, Hungary, Bulgaria, Romania, Estonia, Latvia, and Lithuania, and sells its products to more than 40 countries worldwide.

STADA is a leading manufacturer of high-quality pharmaceuticals that sells its products in approximately 120 countries worldwide.

From COBALT’s side the project was led by partner Martin Simovart and senior associate Madis Reppo with partner Elo Tamm, associate Marit Martens and associate Tiit-Gregor Mets in Estonia, partner Guntars Zīle, senior associates Elīna Ločmele, Uģis Zeltiņš and Kristīne Patmalniece, and associate Diāna Zepa in Latvia, and partners Juozas Rimas and Rasa Zaščiurinskaitė and associates Julija Timoščenko and Samanta Šereikaitė in Lithuania.